Stem Cells in the Context of Cervical Cancer
Journal Title: Journal of Regenerative Medicine & Biology Research - Year 2024, Vol 5, Issue 3
Abstract
Cervical carcinoma exhibits a high mortality among females, particularly in less developed countries. 99.7% of cervical cancer occurs due to an HPV infection. Other factors also contribute to the progression of HPV to cervical cancer including using oral contraceptives long-term, tobacco use, partaking in sexual activity at an early age and having multiple partners, low-socioeconomic status and other sexually transmitted infections. The current standard of care does not provide a cure but rather just prolongs the patient’s survival. Patients that have to undergo surgery are burdened by life-long consequences related to the child-bearing ability and the chances of recurrence are not fully eliminated. The theory of cancer stem cells states that most tumor cells die after transient differentiation, but a small number of tumor cells significantly contribute to oncogenesis due to their ability to proliferate and self-renew indefinitely. Developing a treatment that specifically targets these CCSCs could prevent the new tumors from developing since CCSCs may be at the root of metastasis. Recent discoveries in the field of targeted therapy have shown promise including, but not limited to, immune checkpoint inhibitors, anti-angiogenesis agents, poly (ADP-ribose) polymerase (PARP) inhibitors, targeted gene delivery and nanotechnology.
Authors and Affiliations
Hetvi Solanki1, Vincent S Gallicchio1*
Keywords
Related Articles
- EP ID EP751728
- DOI https://doi.org/10.46889/JRMBR.2024.5303
- Views 41
- Downloads 0
The Future Role of Mesenchymal Stem Cells in Tissue Repair and Medical Therapeutics: Realities and Expectations
Mesenchymal Stem Cells (MSCs); which were first described by Alexander Fridenstein in the 1960s; are heterogeneous, non-hematopoietic, adult multipotent stromal progenitor cells that are capable of self-renewal and dif...
Expression of Neuron Specific Neuronal Nuclei Protein (NeuNNP) by AAV2 Shows Diagnosis Ability in Spinal Cord Injury Using Neural Stem Cells
Fibroblast Growth Factor (FGF) shows promising therapy for Spinal Cord Injury (SCI). Neural stem transplantation has been on the role implementing tactics to repair SCI. Considering the hostile hypoxia condition in SCI...
After Effects of COVID-19 and Repair of Lungs
Lung disease is the most effected organ in patients. Corona (CoV) targets the lungs and causes death of millions of patients across the globe. There has been increasing burden in lung associated disease due to the pand...
A Gout Flare Caused by the Administration of Platelet Rich Plasma: A Clinical Case
The therapy with Platelet Rich Plasma (PRP) administered in degenerated or injured musculoskeletal tissues is a new and promising regenerative treatment option. Traditionally, it is considered that as PRP represents an a...
Unprecedented Year Story to Success
I was thinking of finding what I would discuss in a 2 page new Editorial as I have several matters to say and then destiny made it easy by suddenly receiving three invitations to be nominated for three global awards. S...